Cancer patients to save on PBS drugs
February 4, 2019
Hundreds of West Australians affected by lung cancer will save almost $90,000 a year after the Federal Government listed cancer drug Tagrisso on the Pharmaceutical Benefits Scheme.
Patients paying close to $8000 per prescription for Tagrisso, or almost $88,000 a year, will now be able to get a script for just $40.30 after a $96 million investment by the Government.
The latest PBS listing was recommended by the Independent Pharmaceutical Benefits Advisory Committee and joins 2000 others which, combined, are worth $10.5 billion.
Federal Member for Durack Melissa Price said subsidising medicines like Tagrisso meant patients could manage their cancer at home rather than visiting the hospital for chemotherapy.
"Our Government continues to list every drug on the PBS approved by the PBAC to ensure that new, essential medicines are affordable for all Australians," she said.
"We are now making on average one new or amended PBS listing every single day."
Source - North West Telegraph